PerspectivePRECISION MEDICINE

The evidence landscape in precision medicine

See allHide authors and affiliations

Science Translational Medicine  22 Apr 2020:
Vol. 12, Issue 540, eaaw7745
DOI: 10.1126/scitranslmed.aaw7745

Article Information

vol. 12 no. 540

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication January 23, 2019
  • Accepted for publication October 3, 2019
  • .

Author Information

  1. Spencer Phillips Hey1,2,*,
  2. Cory V. Gerlach3,4,5,
  3. Garrett Dunlap3,6,
  4. Vinay Prasad7 and
  5. Aaron S. Kesselheim1,2
  1. 1Harvard Center for Bioethics, Harvard Medical School, Boston, MA, USA.
  2. 2Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA.
  3. 3Harvard Program in Therapeutic Sciences, Harvard Medical School, Boston, MA, USA.
  4. 4Department of Medicine, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  5. 5Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  6. 6Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, MA, and Therapeutics Graduate Program, Harvard Medical School, Boston, MA, USA.
  7. 7Division of Hematology and Medical Oncology, Knight Cancer Institute, Department of Preventive Medicine and Public Health, and Center for Health Care Ethics, Oregon Health and Science University, Portland, OR, USA.
  1. *Corresponding author. Email: spencer_hey{at}hms.harvard.edu

Altmetric

Article usage

Article usage: April 2020 to June 2020

AbstractFullPdf
Apr 20203163600386
May 2020508128159
Jun 20201585120

Stay Connected to Science Translational Medicine